LETROZOLE CIPLA letrozole 2.5mg film-coated tablet blister pack

Nchi: Australia

Lugha: Kiingereza

Chanzo: Department of Health (Therapeutic Goods Administration)

Viambatanisho vya kazi:

letrozole, Quantity: 2.5 mg

Inapatikana kutoka:

Cipla Australia Pty Ltd

INN (Jina la Kimataifa):

Letrozole

Dawa fomu:

Tablet, film coated

Tungo:

Excipient Ingredients: lactose monohydrate; sodium starch glycollate; microcrystalline cellulose; hypromellose; colloidal anhydrous silica; magnesium stearate; titanium dioxide; iron oxide yellow; macrogol 400

Njia ya uendeshaji:

Oral

Vitengo katika mfuko:

30, 10

Dawa ya aina:

(S4) Prescription Only Medicine

Matibabu dalili:

For the treatment of postmenopausal women with hormone receptor positive breast cancer (see Clinical Trials). The safety and efficacy of neoadjuvant use of letrozole has not been established. Letrozole is not indicated in hormone receptor negative disease.

Bidhaa muhtasari:

Visual Identification: Yellow circular, biconvex, film coated tablet debossed with LT on one side and 2.5 on the other side; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Idhini hali ya:

Licence status A

Idhini ya tarehe:

2016-06-01